10Bloomston M,Frankel WL,Petrocca F,et al.MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis[J].JAMA,2007,297(17):1901.
2Wright WE, Shay JW, Piatyszek MA, et al. Modification of a telomeric repeat amplification protocol(TRAP) result in increased reliability, linearity and sensitivity [J]. Nucleic Acids Res, 1995, 23 ( 18 ) : 3794-3795.
3Hiyama E, Kodama T, Shinbara K, et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors [J]. Cancer Res, 1997,57(2) :326-331.
4Suehara N, Mizumoto K, Kusumoto M, et al. Telomerase activity detected in pancreatic juice, 19 months before a tumor is detected in a patient with pancreatic cancer [J]. Am J Gastroenteral, 1997,93 (10) : 1967-1971.
5Makinen K, Hakala T, Lipponen P, et al. Clinical contribution of bcl-2,p53 and Ki-67 protein in pancreatic ductal adcnocarcinama[J]. Anticancer Rcs, 1998,18(1B) :615-618.
6Rozenblum E,Schutte M, Goggins M, et al. Tumor-auppressive pathways in pancreatic carcinoma [J]. Cancer Res, 1997,57 (9):1731-1734.
7Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004 [J]. CA Cancer J Clin,2004,54(1) :8-29.
9Chang JH, Takeachi T. Clinic significance of measurement of Span-1 antigen in the diagnosis of pancreatic cancer[J] .J Jpn Pancreas Soc,1990,5(2) :80-88.
10Wilentz RE, Slebos RJC, Hruban RH. Screening for pancreatic cancerusing techniques to detect altered gene products[ A]. Howard A. Pan-creatic cancer pathogenesis diagnosis and treatment[ M]. 1st ed.西安:世界图书出版西安公司,1999.113.
